Abstract
There is limited evidence demonstrating a survival advantage of curative-intent surgery for malignant pleural mesothelioma over systemic therapy. This radical surgery (pleurectomy, decortication or extra pleural pneumonectomy) carries a significant risk of increased morbidity and mortality. We sought to evaluate if the addition of curative intent surgery is associated with better survival over multiagent chemotherapy alone in a large population-based study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
